Daily ShareChat: Abano Healthcare
By Jenny Ruth
Abano Healthcare's first-half results show the company's underlying businesses have been hurt by the tough economic conditions but the results are still "surprisingly robust," given the vulnerablilty of many of the businesses to discretionary spending, says McDouall Stuart.
Excluding the $76.6 million net proceeds from the New Zealand Bay Audiology sale, the net profit was $3.4 million, down from $4.1 million last year, although the latest result includes only a five-month contribution from the sold business.
Operating profit fell slightly by 2%, implying that margins have tightened over the last six months and that breaks Abano's record of improving operating profit every year since 2006, the broker says.
The audiology sale has left the company with no New Zealand debt and a gearing ration of 15% relating to Australian dental debt after the company returned 52 cents per share to shareholders and an under-subscribed buyback. (The buyback was under-subscribed by $28.6 million with only $17.3 million taken up.)
Abano is in a strong position to continue its growth strategy through both greenfield investment and acquisition, McDouall Stuart says.
Its remaining businesses are less mature and lower margin but present better growth opportunities. "We continue to see Abano as a solidly managed company with excellent growth prospects."
BROKER CALL: McDouall Stuart rate Abano Healthcare as buy.
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Comments from our readers
No comments yet Add your comment:
Related News
Daily ShareChat: Abano Abano operating profit meets guidance at $4.4M, before Bay sale proceeds Daily ShareChat: Abano Healthcare Abano trims full-year profit guidance as ACC referrals drop; dividend maintained Daily ShareChat: Abano Healthcare Abano first-half profit soars on asset sale proceeds Bay Audiology sells NZ arm Daily ShareChat: Abano Healthcare Abano shares leap on sale of NZ audiology business Daily ShareChat: Abano Healthcare
NZX Annoucements for ABA
|
|
Abano Healthcare Group Limited Ordinary Shares
Current quote:
ABA $5.09
Quotes delayed 20 minutes
Price when article published: $5.78
Previous News
Sharemarket News By Email
Stock Quote
At a Glance
| NZX 50 Index |
3092.36 |
 |
9.90 |
| S&P/ASX 200 |
4532.70 |
 |
0.00 |
| Dow Jones Industrials |
10320.10 |
 |
50.60 |
Comment & Analysis
|
“
One of our mortgages came up for roll-over in the past couple weeks and, after a squizz around www.mortgagerates.co.nz, and a general vague feeling that interest rates are only going to rise from here, we fixed for three years at a bit over 7%.
Who knows if that was the right thing to do? Picking where [...]
”
Pattrick Smellie More »
|
|
|
|


NZX 15 Index
NZX Announcements
|